Hemophilia Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
Hemophilia Market Analysis:
During the forecast period, the hemophilia market is projected to experience a compound annual growth rate (CAGR) of 5.7%. However, the outbreak of COVID-19 had a negative impact on individuals with chronic medical conditions like hemophilia. This vulnerable population had to take extra precautions to reduce the risk of contracting the virus, as they were more susceptible to infectious diseases. A study published in the Journal of Dental and Medical Sciences in August 2020 revealed that the average annualized bleed rate increased significantly from 2.4 to 8.2 during the lockdown in children who were previously on regular prophylaxis. This, along with reasons such as non-availability of transport, fear of coronavirus infection, and high cost of alternate transport, hindered the growth of the market. However, with the easing of pandemic restrictions and the availability of advanced therapies for hemophilia, the market is expected to witness notable growth in the upcoming years.
Several factors contribute to the growth of the hemophilia market, including the increasing prevalence of the condition, favorable government initiatives, and ongoing research and development. According to the World Federation of Hemophilia Global Report 2021, there were 386,966 individuals globally identified with bleeding disorders, out of which 233,577 cases were hemophilia. This high prevalence of hemophilia worldwide is likely to drive the adoption of hemophilia therapies, thereby stimulating market growth. Additionally, government initiatives aimed at improving the diagnosis and treatment of hemophilia, coupled with ongoing research and development activities, are expected to further fuel the expansion of the market.
Get the free sample report of the Hemophilia Market
Comments
Post a Comment